DOJ Moves to Downgrade Marijuana to Schedule III Status

Key Details The U.S. Justice Department is expected to reclassify marijuana from Schedule I to Schedule III as soon as April 22. This shift would place cannabis in a category reserved for drugs with accepted medical uses and lower abuse potential, removing it from the same classification as heroin and LSD. President Trump signed an executive order in December expediting the process. Financial Impact The reclassification could eliminate burdensome taxes on cannabis sales in states where it's legal. Currently, businesses selling Schedule I substances face taxes before deducting operating expenses, with some companies reporting tax rates as high as 56% versus the standard 21% corporate rate. The change could also enable expanded clinical research on marijuana. Why It Matters The American Trucking Associations has expressed significant safety concerns about the reclassification. ATA leadership emphasized that any change must preserve DOT testing authority and drug screening requirements for safety-sensitive workers. Carriers need reliable tools to ensure drivers remain drug and alcohol-free, the association stated. Next Steps While reclassification would not legalize marijuana nationwide, it represents a major shift in federal policy. The DEA initiated the reclassification process nearly two years ago, and momentum appears to be building under the Trump administration's push to expedite the timeline.